Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vilazodone for Separation Anxiety Disorder

NCT01999920 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vilazodone for Separation Anxiety Disorder
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2013
Completion date
December 30, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

separation anxiety disorder